Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Endometrial Neoplasms 3 Breast Neoplasms 3 Ovarian Neoplasms 2 Non Small Cell Lung Carcinoma NSCLC 2 Neoplasms 2 Neoplasm Metastasis 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcopenia 1 Penile Neoplasms 1 Non-Small Cell Lung Cancer With HER2- Mutations 1 Malnutrition 1 Male Urogenital Diseases 1 Lung Neoplasms 1 First-line Advanced NSCLC Patients 1 Fallopian Tube Neoplasms 1 Dysgeusia 1 Carcinoma 1

Interventions

pembrolizumab 34 Cisplatin 29 Paclitaxel 15 Brachytherapy 15 Radiotherapy 14 Carboplatin 14 Bevacizumab 14 Blood Specimen Collection 13 Specimen Handling 12 Magnetic Resonance Spectroscopy 11 Colposcopy 11 Nivolumab 10 Drug Therapy 10 atezolizumab 8 Human Papillomavirus DNA Tests 8 Gemcitabine 8 lenvatinib 7 Radiation 6 Platinum 6 Biopsy 6 toripalimab 5 cemiplimab 5 Surveys and Questionnaires 5 Standard of Care 5 Radiotherapy, Intensity-Modulated 5 Practice Guidelines as Topic 5 Patient Navigation 5 Fulvestrant 5 Fluorodeoxyglucose F18 5 zimberelimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × CP protocol × 1 year × Clear all

NCT04016142 2026-03-18

ACCRAPAN

Centre Oscar Lambret

Phase 2 Terminated

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡